The pandemic has seen 10 years’ worth of health reform rolled out in a matter of weeks – from care delivered via telehealth, through to access and delivery of medicines. There has never been a better time for industry, consumer groups and clinicians to engage with the government on the value that innovation delivers in the sector and what pandemic reforms we want keep and evolve in the longer term.
Join LIFE Agency's Rachel Stanton, Ogilvy Health's Kristina Luburic, and Parker & Partner's Peta Lange for a discussion that considers the avenues open to pharmaceutical and medical device organisations to partner with government to shape the health reform and innovation agendas, and what patient organisations and their supporters and partners need to focus on in the short term to get their needs heard – and funded – by decision makers in the mid-term.
Rachel Stanton - Rachel.Stanton@opragency.com.au
Kristina Luburic - Kristina.Luburic@ogilvy.com
Peta Lange - Peta@p-p.com.au